Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kushenol A is a flavonoid compound isolated from the root of Sophora flavescens. It acts as a **non-competitive tyrosinase inhibitor**, blocking the conversion of L-tyrosine to L-DOPA, and inhibits **alpha-glucosidase** and **beta-amylase** enzymes. Kushenol A demonstrates **antioxidant**, **enzyme inhibitory**, and **anti-proliferative** activities, including reported suppression of cancer cell growth through inhibition of the **PI3K/AKT/mTOR signaling pathway**. Its primary research indications are in dermatology (skin whitening, anti-aging cosmetics), metabolic disorders (enzyme inhibition), and oncology research[1][3][5][9][10]. It is not approved for pharmaceutical use; current availability is for research purposes only.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kushenol a.